Cargando…

Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy

Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes. We implemented fixel-based analysis, Neurite Orientation and Density Imaging (NODDI),...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Trina, Wilkes, Bradley J., Archer, Derek B., Chu, Winston T., Coombes, Stephen A., Lai, Song, McFarland, Nikolaus R., Okun, Michael S., Black, Mieniecia L., Herschel, Ellen, Simuni, Tanya, Comella, Cynthia, Afshari, Mitra, Xie, Tao, Li, Hong, Parrish, Todd B., Kurani, Ajay S., Corcos, Daniel M., Vaillancourt, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062732/
https://www.ncbi.nlm.nih.gov/pubmed/35489192
http://dx.doi.org/10.1016/j.nicl.2022.103022
_version_ 1784699013546639360
author Mitchell, Trina
Wilkes, Bradley J.
Archer, Derek B.
Chu, Winston T.
Coombes, Stephen A.
Lai, Song
McFarland, Nikolaus R.
Okun, Michael S.
Black, Mieniecia L.
Herschel, Ellen
Simuni, Tanya
Comella, Cynthia
Afshari, Mitra
Xie, Tao
Li, Hong
Parrish, Todd B.
Kurani, Ajay S.
Corcos, Daniel M.
Vaillancourt, David E.
author_facet Mitchell, Trina
Wilkes, Bradley J.
Archer, Derek B.
Chu, Winston T.
Coombes, Stephen A.
Lai, Song
McFarland, Nikolaus R.
Okun, Michael S.
Black, Mieniecia L.
Herschel, Ellen
Simuni, Tanya
Comella, Cynthia
Afshari, Mitra
Xie, Tao
Li, Hong
Parrish, Todd B.
Kurani, Ajay S.
Corcos, Daniel M.
Vaillancourt, David E.
author_sort Mitchell, Trina
collection PubMed
description Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes. We implemented fixel-based analysis, Neurite Orientation and Density Imaging (NODDI), and free-water imaging in Parkinson’s disease (PD), multiple system atrophy (MSAp), progressive supranuclear palsy (PSP), and controls longitudinally over one year. Further, we used these three advanced diffusion imaging techniques to investigate longitudinal progression-related effects in key white matter tracts and gray matter regions in PD and two common atypical Parkinsonian disorders. Fixel-based analysis and free-water imaging revealed longitudinal declines in a greater number of descending sensorimotor tracts in MSAp and PSP compared to PD. In contrast, only the primary motor descending sensorimotor tract had progressive decline over one year, measured by fiber density (FD), in PD compared to that in controls. PSP was characterized by longitudinal impairment in multiple transcallosal tracts (primary motor, dorsal and ventral premotor, pre-supplementary motor, and supplementary motor area) as measured by FD, whereas there were no transcallosal tracts with longitudinal FD impairment in MSAp and PD. In addition, free-water (FW) and FW-corrected fractional anisotropy (FAt) in gray matter regions showed longitudinal changes over one year in regions that have previously shown cross-sectional impairment in MSAp (putamen) and PSP (substantia nigra, putamen, subthalamic nucleus, red nucleus, and pedunculopontine nucleus). NODDI did not detect any longitudinal white matter tract progression effects and there were few effects in gray matter regions across Parkinsonian disorders. All three imaging methods were associated with change in clinical disease severity across all three Parkinsonian syndromes. These results identify novel extra-nigral and extra-striatal longitudinal progression effects in atypical Parkinsonian disorders through the application of multiple diffusion methods that are related to clinical disease progression. Moreover, the findings suggest that fixel-based analysis and free-water imaging are both particularly sensitive to these longitudinal changes in atypical Parkinsonian disorders.
format Online
Article
Text
id pubmed-9062732
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90627322022-05-04 Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy Mitchell, Trina Wilkes, Bradley J. Archer, Derek B. Chu, Winston T. Coombes, Stephen A. Lai, Song McFarland, Nikolaus R. Okun, Michael S. Black, Mieniecia L. Herschel, Ellen Simuni, Tanya Comella, Cynthia Afshari, Mitra Xie, Tao Li, Hong Parrish, Todd B. Kurani, Ajay S. Corcos, Daniel M. Vaillancourt, David E. Neuroimage Clin Regular Article Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes. We implemented fixel-based analysis, Neurite Orientation and Density Imaging (NODDI), and free-water imaging in Parkinson’s disease (PD), multiple system atrophy (MSAp), progressive supranuclear palsy (PSP), and controls longitudinally over one year. Further, we used these three advanced diffusion imaging techniques to investigate longitudinal progression-related effects in key white matter tracts and gray matter regions in PD and two common atypical Parkinsonian disorders. Fixel-based analysis and free-water imaging revealed longitudinal declines in a greater number of descending sensorimotor tracts in MSAp and PSP compared to PD. In contrast, only the primary motor descending sensorimotor tract had progressive decline over one year, measured by fiber density (FD), in PD compared to that in controls. PSP was characterized by longitudinal impairment in multiple transcallosal tracts (primary motor, dorsal and ventral premotor, pre-supplementary motor, and supplementary motor area) as measured by FD, whereas there were no transcallosal tracts with longitudinal FD impairment in MSAp and PD. In addition, free-water (FW) and FW-corrected fractional anisotropy (FAt) in gray matter regions showed longitudinal changes over one year in regions that have previously shown cross-sectional impairment in MSAp (putamen) and PSP (substantia nigra, putamen, subthalamic nucleus, red nucleus, and pedunculopontine nucleus). NODDI did not detect any longitudinal white matter tract progression effects and there were few effects in gray matter regions across Parkinsonian disorders. All three imaging methods were associated with change in clinical disease severity across all three Parkinsonian syndromes. These results identify novel extra-nigral and extra-striatal longitudinal progression effects in atypical Parkinsonian disorders through the application of multiple diffusion methods that are related to clinical disease progression. Moreover, the findings suggest that fixel-based analysis and free-water imaging are both particularly sensitive to these longitudinal changes in atypical Parkinsonian disorders. Elsevier 2022-04-26 /pmc/articles/PMC9062732/ /pubmed/35489192 http://dx.doi.org/10.1016/j.nicl.2022.103022 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Mitchell, Trina
Wilkes, Bradley J.
Archer, Derek B.
Chu, Winston T.
Coombes, Stephen A.
Lai, Song
McFarland, Nikolaus R.
Okun, Michael S.
Black, Mieniecia L.
Herschel, Ellen
Simuni, Tanya
Comella, Cynthia
Afshari, Mitra
Xie, Tao
Li, Hong
Parrish, Todd B.
Kurani, Ajay S.
Corcos, Daniel M.
Vaillancourt, David E.
Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
title Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
title_full Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
title_fullStr Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
title_full_unstemmed Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
title_short Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
title_sort advanced diffusion imaging to track progression in parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062732/
https://www.ncbi.nlm.nih.gov/pubmed/35489192
http://dx.doi.org/10.1016/j.nicl.2022.103022
work_keys_str_mv AT mitchelltrina advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT wilkesbradleyj advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT archerderekb advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT chuwinstont advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT coombesstephena advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT laisong advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT mcfarlandnikolausr advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT okunmichaels advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT blackmieniecial advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT herschelellen advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT simunitanya advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT comellacynthia advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT afsharimitra advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT xietao advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT lihong advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT parrishtoddb advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT kuraniajays advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT corcosdanielm advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy
AT vaillancourtdavide advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy